NANOCELLE “ISSUE OF ALLOWANCE” BY US PATENT OFFICE
With this Patent now allowed/granted it has cleared several barriers for partnering discussions.
- With this Patent now allowed/granted it has cleared several barriers for partnering discussions.
- This announcement was authorised by the Board of Directors of Medlab Clinical Limited.
- Medlabs pipeline comprises a number of small and large molecules from repurposing generic medicines to enhancing the delivery of immunotherapies.
- NanoCelle, the patented delivery platform is wholly owned by Medlab and developed in Medlabs owned OGTR Registered Laboratory.